$6.54
0.050.77%
Last update: Oct 27, 5:15 AM
Achieve Life Sciences Inc (ACHV) Stock Price, Quote, News & History
ACHVNASDAQ
Achieve Life Sciences taps Adare for cytisinicline manufacturing as stock falls; reports wider losses and shifts US launch timeline to 2027.
You can purchase shares of Achieve Life Sciences (NASDAQ:ACHV) through any online brokerage.
Other companies in Achieve Life Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Achieve Life Sciences has a consensus price target of $14.90.
The stock price for Achieve Life Sciences (NASDAQ: ACHV) is $7.01 last updated October 27, 2026 at 5:15 AM EDT.
There are no upcoming dividends for Achieve Life Sciences.
Achieve Life Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Achieve Life Sciences.
Achieve Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for...
